A novel oral interleukin-23 receptor antagonist peptide, icotrokinra, for moderate-to- severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials

Inflammopharmacology 2026

View at publisher
Authors: Martin Cevallos-Cueva, Chinenye Onejeme, Laura Ghanem, Lorena Oliveira Fonseca, Stephen K. Tyring
DOI: 10.1007/s10787-026-02149-x
Cited by: 2
References: 36

Fields of Study & Subjects

Psoriasis: Treatment and Pathogenesis Dermatology and Skin Diseases Hidradenitis Suppurativa and Treatments

Publication details

Journal / source
Inflammopharmacology
Publisher
Springer Science and Business Media LLC
Volume
34
Issue
6
Pages
3783–3795
Publication date
3 March 2026
Language
EN